Cargando…

The optimal timing for non-culprit percutaneous coronary intervention in patients with multivessel coronary artery disease: A pairwise and network meta-analysis of randomized trials

BACKGROUND AND AIMS: Recently, several randomized trials have shown that patients with multivessel disease (MVD) often pursue complete revascularization during percutaneous coronary intervention (PCI) to improve their prognosis. However, the optimal time for the non-culprit artery has been controver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Yujia, Li, Shu, Hu, Sihan, Wan, Jing, Shao, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548605/ https://www.ncbi.nlm.nih.gov/pubmed/36225962 http://dx.doi.org/10.3389/fcvm.2022.1000664

Ejemplares similares

Multivessel vs. culprit vessel-only percutaneous coronary intervention in ST-segment elevation myocardial infarction with and without cardiogenic shock
por: Wu, Jing, et al.
Publicado: (2022)

Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease: A One-Stage Meta-Analysis
por: Chew, Nicholas W. S., et al.
Publicado: (2022)

Staged revascularization vs. culprit-only percutaneous coronary intervention for multivessel disease in elderly patients with ST-segment elevation myocardial infarction
por: Lang, Jiachun, et al.
Publicado: (2022)

Multivessel vs. Culprit Vessel-Only Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction in Patients With Cardiogenic Shock: An Updated Systematic Review and Meta-Analysis
por: Xiong, Bingquan, et al.
Publicado: (2022)

STEMI patients receiving percutaneous coronary intervention for a culprit lesion with coronary artery bifurcation—efficacy and safety of the jailed semi-inflated balloon
por: Lin, Tzu-Hsiang, et al.
Publicado: (2023)

Clinical and economic impact of coronary artery bypass graft and percutaneous coronary intervention in young individuals with acute coronary syndromes and multivessel disease: A real-world comparison in a middle-income country
por: Alexim, Gustavo de Almeida, et al.
Publicado: (2022)

One-Stop Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass Grafting in Patients With Multivessel Coronary Artery Disease
por: Li, Dongjie, et al.
Publicado: (2021)

Culprit vessel vs. immediate multivessel vs. out-of-hospital staged intervention for patients with non-ST-segment elevation myocardial infarction and multivessel disease
por: Wang, Chen, et al.
Publicado: (2022)

Multivessel versus Culprit-Only Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome
por: Pustjens, Tobias F. S., et al.
Publicado: (2022)

Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis
por: Cui, Kongyong, et al.
Publicado: (2022)

Prognostic stratification of older patients with multivessel coronary artery disease treated with percutaneous transluminal coronary angioplasty based on clinical and biochemical measures: protocol for a prospective cohort study
por: Carmona-Segovia, Ada del Mar, et al.
Publicado: (2022)

Comparison of clinical outcomes between culprit vessel only and multivessel percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel coronary diseases
por: Ryu, Kwang Sun, et al.
Publicado: (2015)

Culprit Vessel Only versus Multivessel Percutaneous Coronary Intervention in Patients Presenting with ST-Segment Elevation Myocardial Infarction and Multivessel Disease
por: Zhang, Dongfeng, et al.
Publicado: (2014)

Hybrid coronary revascularization vs. percutaneous coronary interventions for multivessel coronary artery disease
por: Hannan, Edward L., et al.
Publicado: (2021)

Incident Heart Failure in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Gu, Jun, et al.
Publicado: (2021)

Correction: Culprit Vessel Only versus Multivessel Percutaneous Coronary Intervention in Patients Presenting with ST-Segment Elevation Myocardial Infarction and Multivessel Disease
Publicado: (2014)

Correction: Culprit Vessel Only versus Multivessel Percutaneous Coronary Intervention in Patients Presenting with ST-Segment Elevation Myocardial Infarction and Multivessel Disease
Publicado: (2014)

Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes
por: Cui, Kongyong, et al.
Publicado: (2019)

The optimal percutaneous coronary intervention strategy for patients with ST-segment elevation myocardial infarction and multivessel disease: a pairwise and network meta-analysis
por: Hu, Meng-Jin, et al.
Publicado: (2022)

Thrombosis and Major Bleeding Risk After Primary PCI Among Patients With Multivessel Coronary Artery Disease
por: Zhao, Xiaoxiao, et al.
Publicado: (2022)

Culprit vessel revascularization first with primary use of a dedicated transradial guiding catheter to reduce door to balloon time in primary percutaneous coronary intervention
por: Guo, Jincheng, et al.
Publicado: (2022)

Case report: Constrictive pericarditis after coronary artery perforation during percutaneous coronary intervention
por: Kim, Kyung An, et al.
Publicado: (2023)

One-stage hybrid coronary revascularization for the treatment of multivessel coronary artery disease— Periprocedural and long-term results from the “HYBRID-COR” feasibility study
por: Sanetra, Krzysztof, et al.
Publicado: (2022)

Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
por: Xi, Ziwei, et al.
Publicado: (2021)

Impact of premature coronary artery disease on adverse event risk following first percutaneous coronary intervention
por: Pinxterhuis, Tineke H., et al.
Publicado: (2023)

Instantaneous wave-free ratio guided multivessel revascularisation during percutaneous coronary intervention for acute myocardial infarction: study protocol of the randomised controlled iMODERN trial
por: Beijnink, Casper W H, et al.
Publicado: (2021)

Editorial: Advances in Percutaneous Coronary Intervention
por: Silverio, Angelo, et al.
Publicado: (2022)

Association Between the Expression of MicroRNA-125b and Survival in Patients With Acute Coronary Syndrome and Coronary Multivessel Disease
por: Gager, Gloria M., et al.
Publicado: (2022)

Cardiovascular magnetic resonance in emergency patients with multivessel disease or unobstructed coronary arteries: a cost-effectiveness analysis in the UK
por: Stokes, Elizabeth A, et al.
Publicado: (2019)

ALB-dNLR Score Predicts Mortality in Coronary Artery Disease Patients After Percutaneous Coronary Intervention
por: Xiu, Wen-Juan, et al.
Publicado: (2022)

Long-Term Beta-Blocker Therapy in Patients With Stable Coronary Artery Disease After Percutaneous Coronary Intervention
por: Lee, Seung-Jun, et al.
Publicado: (2022)

The influence of testosterone on the risk of cardiovascular events after percutaneous coronary intervention
por: Chiang, Cheng-Hung, et al.
Publicado: (2022)

Clinical Insights to Complete and Incomplete Surgical Revascularization in Atrial Fibrillation and Multivessel Coronary Disease
por: Pasierski, Michal, et al.
Publicado: (2022)

Clinical outcomes of percutaneous coronary intervention for de novo lesions in small coronary arteries: A systematic review and network meta-analysis
por: Ma, Wen-Rui, et al.
Publicado: (2022)

Correlation Between Smoking Paradox and Heart Rhythm Outcomes in Patients With Coronary Artery Disease Receiving Percutaneous Coronary Intervention
por: Wu, Han-Ping, et al.
Publicado: (2022)

Percutaneous Coronary Intervention in Familial Hypercholesterolemia Is Understudied
por: Ungar, Leo, et al.
Publicado: (2018)

Temporal Trends in Complex Percutaneous Coronary Interventions
por: Kheifets, Mark, et al.
Publicado: (2022)

Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease
por: Yamamoto, Ko, et al.
Publicado: (2023)

Impact of serum uric acid levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome and hypertension after percutaneous coronary intervention: a prospective cohort study
por: Zhang, Shiyu, et al.
Publicado: (2022)

Retrospective cohort analysis of Spanish national trends of coronary artery bypass grafting and percutaneous coronary intervention from 1998 to 2017
por: Carnero Alcazar, Manuel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9cd456v5n4ui0r89dv3bcmhesp